Assessment of coronary reperfusion in patients with myocardial infarction using fatty acid binding protein concentrations in plasma

Heart

Volumn 85, Issue 3, 2001, Pages 278-285

  De Groot, M J M ^a   Muijtjens, A M M ^b   Simoons, M L ^c   Hermens, W T ^a   Glatz, J F C ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cardiac marker proteins; Myocardial reperfusion

Indexed keywords

2 HYDROXYBUTYRATE DEHYDROGENASE; CREATINE KINASE MB; FATTY ACID BINDING PROTEIN; FIBRINOLYTIC AGENT; HEPARIN; MYOGLOBIN; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY REPERFUSION; DIAGNOSTIC ACCURACY; ENZYME ACTIVITY; FEMALE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HEART INFARCTION SIZE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ST SEGMENT ELEVATION;

EID: 0034762556     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.85.3.278     Document Type: Article

References (31)

1. Prediction of infarct coronary artery recanalization after intravenous thrombolytic therapy
2. Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis
3. Early noninvasive detection of successful reperfusion in patients with acute myocardial infarction
4. Usefulness of a rapid initial increase in plasma creatine kinase activity as a marker of reperfusion during thrombolytic therapy for acute myocardial infarction
5. Detection of coronary artery reperfusion with creatine kinase-MB determinations during thrombolytic therapy: Correlation with acute angiography
6. Analysis of creatine kinase, CK-MB, myoglobin, and troponin T time-activity curves for early assessment of coronary artery reperfusion after intravenous thrombolysis
7. Early detection of coronary reperfusion by rapid assessment of plasma myoglobin
8. Fatty-acid-binding protein as a plasma marker for the estimation of myocardial infarct size in humans
9. Serum and urinary human heart fatty acid-binding protein in acute myocardial infarction
10. Fatty acid binding protein and the early detection of acute myocardial infarction: The EUROCARDI multicenter trial
11. Serum concentrations of myoglobin vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction
12. Quantitative analysis of plasma enzyme levels based upon simultaneous determination of different enzymes
13. Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: Influence of early infarct related artery patency. The GUSTO Enzyme Substudy
14. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction
15. The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings
16. One-step enzyme-linked immunosorbent assay (ELISA) for plasma fatty acid-binding protein
17. Measurement of myocardial infarct size from plasma fatty acid-binding protein or myoglobin, using individually estimated clearance rates
18. Value of admission electrocardiogram in predicting outcome of thrombolytic therapy in acute myocardial infarction
19. A method of comparing the areas under receiver operating characteristic curves derived from the same cases
20. Early detection of successful coronary reperfusion based on serum concentration of human heart-type cytoplasmic fatty acid-binding protein
21. Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein
22. Myoglobin, creatine kinase MB, and cardiac troponin-I to assess reperfusion after thrombolysis for acute myocardial infarction: Results from TIMI 10A
23. Rapid diagnosis of coronary reperfusion by measurement of myoglobin level every 15 min in acute myocardial infarction
24. Early detection of successful coronary reperfusion based on serum myoglobin concentration: Comparison with serum creatine kinase isoenzyme MB activity
25. Non-invasive detection of reperfusion after thrombolysis based on serum creatine kinase MB changes and clinical variables
26. Assessment of coronary reperfusion after thrombolysis with a model combining myoglobin, creatine kinase-MB, and clinical variables
27. TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction: Ventriculographic, enzymatic, and electrocardiographic evidence from the TEAM-3 study
28. Biochemical markers of thrombolytic success
29. Significance of initial ST segment elevation and depression for the management of thrombolytic therapy in acute myocardial infarction
30. Value of electrocardiogram in predicting and estimating infarct size in man